NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
This grant funds research on omics phenotypes related to heart, lung, and blood disorders.
About this program
The NHLBI TOPMed grant focuses on understanding the genetic and molecular underpinnings of heart, lung, and blood disorders through omics research. It aims to support innovative studies that utilize advanced technologies to analyze biological data and improve health outcomes. This grant is intended for researchers and institutions engaged in clinical and translational research in the field of cardiovascular, pulmonary, and hematological health. Eligible applicants include academic institutions, research organizations, and other entities with the capacity to conduct high-quality research. The grant encourages collaboration among multidisciplinary teams to enhance the understanding of complex disorders and develop targeted interventions. The research funded by this grant is expected to contribute significantly to the scientific community's knowledge and ultimately improve patient care.
Eligibility
Academic institutions, research organizations, and other entities engaged in relevant research.